Association between Clauss fibrinogen concentration and ROTEM(R) FIBTEM A5 in women with postpartum haemorrhage: validation of cut-off points
Gillissen, A.; Golyardi, B.; van den Akker, T.; Caram Deelder, C.; D.C.A. Henriquez, D.; W.M. Bloemenkamp, K.; J. Duvekot, J.; P. M. de Maat, M.; Eikenboom, J.; G. van der Bom, J.
Show abstract
ObjectivePoint-of-care tests like FIBTEM A5 have been proposed to guide the treatment of patients who might have low fibrinogen concentrations ([≤]2 g/L). The aim of this study was to describe fibrinogen concentrations according to previously proposed FIBTEM A5 cut-off points in blood samples collected from women during postpartum haemorrhage. Design and settingProspective multicentre cohort study Population511 women sustaining postpartum haemorrhage. A total of 637 blood samples were drawn during haemorrhage. MethodsClauss fibrinogen concentrations and ROTEM(R) FIBTEM A5 values were studied to assess the diagnostic properties of previously proposed FIBTEM A5 cut-off points for the detection of low fibrinogen concentrations. Main outcome measuresYouden index, sensitivity and specificity ResultsOf 511 women with a median total volume of blood loss of 1500 mL (IQR 1200 to 2000) 31 women (6%) developed Clauss fibrinogen concentrations below 2 g/L. Using FIBTEM A 5 cut-off of [≤] 7 mm: 48% of cases with Clauss fibrinogen [≤]2 g/L were missed (FIBTEM A5 > 7mm), and of the 28 samples with FIBTEM A5 [≤] 7mm, 12 (43%) samples had Clauss fibrinogen >2 g/L. Using FIBTEM A5 cut-off of [≤]12mm: 13% of cases with Clauss fibrinogen [≤]2 g/L were missed and of the 145 samples with a FIBTEM A5 [≤]12 mm, 118 had Clauss fibrinogen >2 g/L, resulting in false positive selection of 81% of women. Using FIBTEM A5 [≤] 15 mm: 97% (30/31) of the samples with Clauss fibrinogen [≤]2 g/L were accurately selected; yet 89% (248/278) of samples that were selected had a fibrinogen concentration of >2 g/L. Based on the Youden index, the optimal cut-off point in our cohort was a FIBTEM A5 of 12mm with sensitivity 87% and specificity 81%. ConclusionsOur findings suggest that if FIBTEM A5 lower than 12 mm would have been used to detect women with fibrinogen concentrations below 2 g/L in order to treat them with fibrinogen concentrate, 87 % of the women with fibrinogen below 2 g/L would correctly have received fibrinogen. However, most women (81%) receiving fibrinogen concentrate would not have needed it, because they had plasma fibrinogen concentrations above 2 g/L. Fundingno funding was obtained to conduct this research
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Changes in pregnancy-related serum biomarkers early in gestation are associated with later development of preeclampsia 94%
- Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients 94%
- Experience in the implementation of the early warning sign system in obstetric patients (Maternal Early Warning Criteria, MEWC) during early postpartum. A prospective observational study 93%
Similar papers in this journal
- Does the elevated (thrombosis risk of males relative to females help account for the excess male mortality observed in Covid-19? An observational study 92%
- Case finding of early pregnancies at risk of preeclampsia using maternal blood leptin/ceramide ratio 91%
- Birhan Maternal and Child Health cohort: a study protocol 91%
Similar papers in this journal
- Reduction in Spontaneous and Iatrogenic Preterm Births in Twin Pregnancies During COVID-19 Lockdown in Melbourne, Australia: A Multicenter Cohort Study 92%
- Comparison of first trimester dating methods for gestational age estimation and their implication on preterm birth classification in a North Indian cohort 92%
- Maternal and perinatal characteristics and outcomes of pregnancies complicated with COVID-19 in Kuwait 91%
Similar papers in this journal
- Macrophage polarization in cesarean scar diverticulum 88%
- Mid-Regional pro-Adrenomedullin (MR-proADM), C-Reactive Protein (CRP) and Other Biomarkers in the Early Identification of Disease Progression in COVID-19 Patients in the Acute NHS Setting 88%
- Kinetics of SARS-CoV-2 antibody responses pre- and post- COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study 88%
Similar papers in this journal
- Pregnancy-induced changes in blood composition drive post-partum hemorrhage risk 94%
- Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease 93%
- Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.